Repatha (evolocumab) is a medication used with other medicines to treat people with high blood cholesterol levels (hypercholesterolemia) and cardiovascular disease.
Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.
Verquvo (vericiguat) is a medication to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%
